Showing results (41-50 of 89) with videos related to
Sort By:
Pageof 9
Journal of Cancer Research and Therapeutics|May 6, 2023
Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?Mustafa Korkmaz, Melek K Eryılmaz, Mehmet Z Koçak, et al.European Journal of Clinical Pharmacology|February 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapyİsmail Beypınar, Semiha Urvay, Müslih Ürün, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 23, 2024
Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancerOğuzhan Yıldız, Ali Fuat Gürbüz, Melek Karakurt Eryılmaz, et al.Laryngoscope Investigative Otolaryngology|June 25, 2026
Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing LossBilgeşah Kılıçtaş, Ahmet Ufuk Kılıçtaş, Rukiye Özçelik Erdem, et al.Medicina (Kaunas, Lithuania)|June 26, 2026
Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell CarcinomaAli Fuat Gürbüz, Mehmet Zahid Koçak, Oğuzhan Yıldız, et al.Medicina (Kaunas, Lithuania)|January 28, 2026
Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and AbirateroneBahattin Engin Kaya, Mehmet Zahid Koçak, Oğuzhan Yıldız, et al.Medicina (Kaunas, Lithuania)|February 27, 2026
Prognostic Significance of Albumin-Bilirubin (ALBI) Score in Gastric Cancer Patients Undergoing Curative Resection Followed by Adjuvant TherapyTalat Aykut, Oğuzhan Yıldız, Bahattin Engin Kaya, et al.Journal of Gastrointestinal Cancer|September 22, 2023
Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?Mustafa Korkmaz, Melek Karakurt Eryılmaz, Muhammed Muhiddin Er, et al.Journal of Clinical Medicine|May 27, 2026
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 InhibitorsTalat Aykut, Mehmet Zahid Koçak, Oğuzhan Yıldız, et al.Current Medical Research and Opinion|June 10, 2024
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group StudyKadriye Bir Yücel, Muzaffer Uğraklı, Serhat Sekmek, et al.Pageof 9